Crossmark

Prevalence of iatrogenic atrial septal defects (iASD) after mitral valve (MV) transcatheter edge-to-edge repair (TEER) in the long-term follow-up

Crossref DOI link: https://doi.org/10.1136/openhrt-2021-001732

Published Online: 2021-10-26

Published Print: 2021-10

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Paukovitsch, Michael https://orcid.org/0000-0002-8056-3908
Schneider, Leonhard Moritz

Reichart, Christine

Nita, Nicoleta

Rottbauer, Wolfgang

Keßler, Mirjam

Markovic, Sinisa https://orcid.org/0000-0001-9708-0702
Clinical Trials ^BETA

Clinical trials referenced in this document:

nct03104660 at ClinicalTrials.gov

Documents that mention this clinical trial

Prevalence of iatrogenic atrial septal defects (iASD) after mitral valve (MV) transcatheter edge-to-edge repair (TEER) in the long-term follow-up
https://doi.org/10.1136/openhrt-2021-001732
License Information

License valid from 2021-10-26